Verve Therapeutics, Inc.
VERV
$6.16
-$0.06-0.97%
| Weiss Ratings | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.68 | |||
| Price History | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.19% | |||
| 30-Day Total Return | -51.03% | |||
| 60-Day Total Return | -38.45% | |||
| 90-Day Total Return | -51.95% | |||
| Year to Date Total Return | -52.43% | |||
| 1-Year Total Return | -57.87% | |||
| 2-Year Total Return | -57.95% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -70.96% | |||
| 52-Week Low % Change | 2.81% | |||
| Price | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $21.42 | |||
| 52-Week Low Price | $6.42 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Jun 16, 2023 | |||
| Valuation | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 555.23M | |||
| Enterprise Value | 6.19M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.13 | |||
| Earnings Per Share Growth | 7.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 39.36 | |||
| Price/Book (Q) | 0.91 | |||
| Enterprise Value/Revenue (TTM) | -2.46 | |||
| Price | $6.66 | |||
| Enterprise Value/EBITDA (TTM) | 0.13 | |||
| Enterprise Value/EBIT | 0.13 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 69.67M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 603 0070 | |||
| Address | 201 Brookline Avenue Cambridge, MA 02215 | |||
| Website | www.vervetx.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,897.63% | |||
| Profit Margin | -1,701.54% | |||
| Management Effectiveness | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -19.48% | |||
| Return on Equity | -- | |||
| Income Statement | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 11.76M | |||
| Total Revenue (TTM) | 11.76M | |||
| Revenue Per Share | $0.17 | |||
| Gross Profit (TTM) | -173.19M | |||
| EBITDA (TTM) | -217.67M | |||
| EBIT (TTM) | -223.12M | |||
| Net Income (TTM) | -200.07M | |||
| Net Income Avl. to Common (TTM) | -200.07M | |||
| Total Revenue Growth (Q YOY) | 408.30% | |||
| Earnings Growth (Q YOY) | -17.69% | |||
| EPS Diluted (TTM) | -3.13 | |||
| EPS Diluted Growth (Q YOY) | -3.83% | |||
| Balance Sheet | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 623.95M | |||
| Cash Per Share (Q) | $8.96 | |||
| Total Current Assets (Q) | 637.95M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 599.50M | |||
| Current Ratio (Q) | 17.239 | |||
| Book Value Per Share (Q) | $7.31 | |||
| Total Assets (Q) | 752.69M | |||
| Total Current Liabilities (Q) | 37.01M | |||
| Total Debt (Q) | 74.91M | |||
| Total Liabilities (Q) | 153.19M | |||
| Total Common Equity (Q) | 599.50M | |||
| Cash Flow | VERV - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 27.69M | |||
| Cash from Financing (TTM) | 212.58M | |||
| Net Change in Cash (TTM) | 90.72M | |||
| Levered Free Cash Flow (TTM) | -110.19M | |||
| Cash from Operations (TTM) | -149.55M | |||
